Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study

BACKGROUND: Pneumococcal vaccine provides protection against invasive pneumococcal disease in population at risk. This study was conducted to compare the antibody response to 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in patients with thalassemia major...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezai, Mohammad Sadegh, Ghaffari, Javad, Mahdavi, Mohammadreza, Bahari, Amir, Ala, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412244/
https://www.ncbi.nlm.nih.gov/pubmed/28503278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412244/
https://www.ncbi.nlm.nih.gov/pubmed/28503278

Ejemplares similares